Factors associated with change in treatment plan: WHO performance status > 1, high age-adjusted Charlson score, polymedication. »
04/08/25

Age exceeding 66.3 years recognized as critical risk factor. »
04/08/25

TMQ0153 treatment reduces tumor volume and weight in MV4-11 xenografts in vivo. »
04/07/25

Women whose IGFBP-3 levels were in top quartile appeared to have lower expression of stromal CD24. »
04/07/25

Difference between radiological and surgical PCI did not differ significantly based on imaging modality. »
04/11/25

Multivariate analysis identified T4 stage and lymph node metastases as independent risk factors. »
04/11/25

AFT model demonstrated strong predictive performance in survival analysis. »
04/11/25

High fat indices and high FMR strong predictors of poor OS. »
04/11/25

DL models can automate IGTV delineation. »
04/18/25

Bioinformatic analysis highlighted pathways related to microRNAs. »
04/18/25